Children deserve the same rights we do: the need for paediatric pulmonary arterial hypertension clinical drug development

被引:8
|
作者
Barst, Robyn J. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Paediat, New York, NY 10027 USA
关键词
SURVIVAL; REGISTRY; THERAPY; FRANCE;
D O I
10.1136/hrt.2010.195248
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1337 / 1338
页数:2
相关论文
共 50 条
  • [41] Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
    Venitz, Juergen
    Zack, Julia
    Gillies, Hunter
    Allard, Martine
    Regnault, Jean
    Dufton, Christopher
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (12): : 1784 - 1805
  • [42] Special investigations in anti-angiogenic drug development:: What do we have and what do we need?
    Rüegg, C
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 27 - 27
  • [43] Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
    Correale, Michele
    Ferraretti, Armando
    Monaco, Ilenia
    Grazioli, Davide
    Di Biase, Matteo
    Brunetti, Natale Daniele
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2018, 14 : 253 - 264
  • [44] Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development
    Ghataorhe, P.
    Rhodes, C. J.
    Harbaum, L.
    Attard, M.
    Wharton, J.
    Wilkins, M. R.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2017, 282 (02) : 129 - 141
  • [45] Where do we go from here? Reappraising the data on anticoagulation in pulmonary arterial hypertension
    Cirulis, Meghan M.
    Ryan, John J.
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (05) : E298 - E304
  • [46] 30 Years of Children's Rights "Our Children have it good in Austria. Why do we still need Children's Rights?"
    Schaffelhofer-Garcia Marquez, Elisabeth
    [J]. PAEDIATRIE UND PAEDOLOGIE, 2020, 55 (SUPPL 2): : 62 - 66
  • [47] Clinical differences between children and adults with idiopathic and heritable pulmonary arterial hypertension
    Takatsuki, Shinichi
    Shimokawahara, Hiroto
    Shimizu, Yurika
    Kawai, Reiko
    Matsuura, Hiroyuki
    Matsubara, Hiromi
    [J]. CARDIOLOGY IN THE YOUNG, 2023, 33 (10) : 1909 - 1912
  • [48] Update on pulmonary arterial hypertension in children: management strategies and clinical utility of sildenafil
    Wardle, Andrew
    Tulloh, Robert
    [J]. PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 59 - 67
  • [49] Clinical Safety, Pharmacokinetics, and Efficacy of Ambrisentan Therapy in Children With Pulmonary Arterial Hypertension
    Takatsuki, Shinichi
    Rosenzweig, Erika B.
    Zuckerman, Warren
    Brady, Daniela
    Calderbank, Michelle
    Ivy, D. Dunbar
    [J]. PEDIATRIC PULMONOLOGY, 2013, 48 (01) : 27 - 34
  • [50] How Long Can We Leave Patients With Pulmonary Arterial Hypertension on Oral Drug Monotreatment?
    Ogawa, Aiko
    Matsubara, Hiromi
    [J]. CIRCULATION JOURNAL, 2012, 76 (05) : 1089 - 1090